|
1
|
venBio Partners
San Francisco,
California
|
$58.5M
|
–
|
–
|
–
|
|
|
2
|
Fidelity Investments
Boston,
Massachusetts
|
$47.1M
|
+$3.59M
|
+292,184
|
+4%
|
|
|
3
|
Vivo Capital
Palo Alto,
California
|
$25.4M
|
–
|
–
|
–
|
|
|
4
|
Redmile Group
San Francisco,
California
|
$24.3M
|
-$3.57M
|
-290,058
|
-7%
|
|
|
5
|
Vestal Point Capital
New York
|
$21.7M
|
+$12.2M
|
+990,000
|
+38%
|
|
|
6
|
|
$16.2M
|
+$5.73M
|
+466,058
|
+21%
|
|
|
7
|
MPM BioImpact
Boston,
Massachusetts
|
$13.2M
|
+$11.2M
|
+912,393
|
+72%
|
|
|
8
|
|
$11.4M
|
-$10.1M
|
-823,508
|
-30%
|
|
|
9
|
Vanguard Group
Malvern,
Pennsylvania
|
$10.4M
|
+$1.98M
|
+160,784
|
+10%
|
|
|
10
|
Paradigm Biocapital Advisors
New York
|
$9.5M
|
+$19.4M
|
+1,575,605
|
New
|
|
|
11
|
Millennium Management
New York
|
$7.99M
|
+$15.6M
|
+1,265,006
|
+2,102%
|
|
|
12
|
State Street
Boston,
Massachusetts
|
$4.25M
|
+$1.87M
|
+151,680
|
+27%
|
|
|
13
|
Geode Capital Management
Boston,
Massachusetts
|
$4.22M
|
+$1.18M
|
+95,692
|
+16%
|
|
|
14
|
|
$4.06M
|
+$4.06M
|
+330,221
|
+96%
|
|
|
15
|
Marshall Wace
London,
United Kingdom
|
$3.83M
|
+$6.32M
|
+514,133
|
+423%
|
|
|
16
|
Renaissance Technologies
New York
|
$2.64M
|
+$2.51M
|
+204,100
|
+87%
|
|
|
17
|
Privium Fund Management
Amsterdam,
Netherlands
|
$2.27M
|
+$4.88M
|
+396,966
|
New
|
|
|
18
|
Kennedy Capital Management
St Louis,
Missouri
|
$1.85M
|
+$3.78M
|
+307,529
|
New
|
|
|
19
|
Point72 Asset Management
Stamford,
Connecticut
|
$1.83M
|
+$3.74M
|
+304,100
|
New
|
|
|
20
|
Two Sigma Investments
New York
|
$1.76M
|
+$2.79M
|
+226,771
|
+346%
|
|
|
21
|
Northern Trust
Chicago,
Illinois
|
$1.47M
|
-$8.13K
|
-661
|
-0.3%
|
|
|
22
|
Charles Schwab
San Francisco,
California
|
$1.42M
|
+$323K
|
+26,261
|
+13%
|
|
|
23
|
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$1.4M
|
+$2.85M
|
+232,022
|
New
|
|
|
24
|
|
$1.3M
|
+$716K
|
+58,250
|
+37%
|
|
|
25
|
Cubist Systematic Strategies
Stamford,
Connecticut
|
$1.2M
|
+$2.45M
|
+199,441
|
New
|
|
